This study, using gain and loss of function experiments, highlighted how the altered sFRP2 expression had no effect on tumor cell proliferation, but significantly affected the migratory and invasive potential of OS cells, both in vitro and in vivo [42]. The gene discussed is SFRP2; the disease is neoplasm.